Journal
TRENDS IN MOLECULAR MEDICINE
Volume 19, Issue 10, Pages 633-642Publisher
CELL PRESS
DOI: 10.1016/j.molmed.2013.08.002
Keywords
miRNAs; sensitivity to therapy; mechanisms of resistance; molecular therapies
Funding
- Associazione Italiana per la Ricerca sul Cancro (AIRC)
Ask authors/readers for more resources
The discovery of oncogene addiction dramatically changed the therapeutic approach for cancer treatment, and many drugs targeting specific molecular alterations are now in clinics. Despite the big success of these new compounds, the main limit to their efficacy is represented by resistance to therapy. The alteration of the activity or of the expression of many proteins has already been linked to the onset of resistance, but recent evidence indicates a role of microRNAs (miRNAs) as well. In this context, the idea of exploiting miRNAs as predictors of response or resistance to cancer therapy represents an intriguing possibility. The purpose of this review is to address the relationship between miRNAs and targeted therapies response and resistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available